Sign in

CIK 0001404644 · Non-accelerated filer<br>Smaller reporting company

Neurogene Inc.

Sign in to watch
Ticker
NGNE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
980542593
Phone
(877) 237-5020
Business address
535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
Former names
Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. 4 Insider Changes in Ownership
  4. 8-K/A Event Exhibits
  5. 8-K Event Material agreement
  6. DEFA14A Proxy Proxy Materials
  7. DEF 14A Proxy Proxy Statement
  8. PRE 14A Proxy Proxy Statement (Preliminary)
  9. 4/A Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 3 Insider Initial Statement of Ownership
  13. SC 13D/A Stake Beneficial Ownership Report
  14. 4 Insider Changes in Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 8-K Event Material agreement · Acquisition or sale completed · New debt or obligation · Unregistered share sale · Executive or director change · Bylaws or fiscal year change · Other events
  19. 4 Insider Changes in Ownership
  20. SC 13D/A Stake Beneficial Ownership Report

Page 23 of 38 · 752 filings